Abstract 169P
Background
The tumour microenvironment (TME) in glioblastoma includes tumour-associated macrophages (TAMs), with microglia-derived (Mig-TAMs) being pro-inflammatory and monocyte-derived (Mon-TAMs) being tolerogenic (Atunes et al, 2021). This study uses single-cell RNA sequencing (scRNAseq) to explore TAM dynamics and T cell exhaustion in newly diagnosed (ndGBM) and recurrent GBM (rGBM), aiming to uncover distinct TME profiles.
Methods
We analysed scRNA datasets from two studies in the EMBL-EBI database, encompassing ndGBM and rGBM. TAM clusters were reproduced by the Louvain algorithm and annotation by Seurat, followed by manual curation of TAM subsets. We compared Mig-TAMs and Mon-TAMs by their phenotypes and proportions of the overall TAM cluster (using normalised mean cell counts). We correlated the TAM subsets with T cell exhaustion and interferon gene signature.
Results
Our analysis included seven patients (ndGBM=3, rGBM=4), examining 47,965 cells and 23,944 genes. We identified 19 Louvain clusters. The TAM cluster comprised two subsets: Mon-TAMs (markers: LGALS1+, S100A10+, MIF1+) and Mig-TAMs (markers: CD74+, C1QB+, C1QC+). In ndGBM, the mean cell count ratio of Mon-TAMs to total TAM was 0.45 (95% CI, 0.42–0.87), and Mig-TAMs was 0.54 (95% CI, 0.12–0.95, t(2)=4.73, p=0.042). In rGBM, Mon-TAMs had a ratio of 0.65 (95% CI, 0.16–1.19), and Mig-TAMs was 0.34 (95% CI, -0.19–0.88, t(3)=3.87, p=0.03). In the recurrent GBM samples (rGBM), T cell exhaustion markers (IL2RA, ICOS, CTLA4, TIGIT) were significantly more expressed, chemokine and interferon gene signatures were significantly reduced and we observed a predominance of the Mon-TAM cluster compared to the Mig-TAM cluster. Interestingly, in the treatment naïve group (ndGBM), we observed no signals of T cell exhaustion and high Mig-TAM cluster prevalence compared to the Mon-TAM cluster. In concordance, we observed increased interferon gamma gene signature and increased CXCL10 expression (≥50%), which are known predictors for immunotherapy response.
Conclusions
The immunoactive Mig-TAM populations and gene expression signatures in treatment-naive GBM could facilitate translational hypothesis and patient enrichment for future immunotherapy studies in GBM.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
71P - When neighbors play a role: The importance of interacting proteins in the tumorigenic effect of cancer driver genes
Presenter: Margarida Carrolo
Session: Cocktail & Poster Display session
Resources:
Abstract
72P - SNCG promotes the malignant progression of hepatocellular carcinoma by activation EGFR signaling and recycling
Presenter: Yue Chen
Session: Cocktail & Poster Display session
Resources:
Abstract
73P - TROP2 amplification is highly present in dedifferentiated liposarcoma: Data from the Cancer Genome Atlas (TCGA) in soft tissue sarcoma
Presenter: Sarah Orlando
Session: Cocktail & Poster Display session
Resources:
Abstract
74P - The influence of genetic phenotype on prognosis of osteosarcoma
Presenter: Nasirov Kamalovich
Session: Cocktail & Poster Display session
Resources:
Abstract
76P - Immune engager compounds screening using CRC patient-derived organoids
Presenter: Claudia Maria A. Pinna
Session: Cocktail & Poster Display session
Resources:
Abstract
77P - Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer
Presenter: Juan Jiménez-Vacas
Session: Cocktail & Poster Display session
Resources:
Abstract
78P - Exploring ecDNA heterogeneity and evolution in non-small cell lung cancer
Presenter: Jeanette Kittel
Session: Cocktail & Poster Display session
Resources:
Abstract
79P - Targeting galectin-9 in BRCA mutant breast cancer
Presenter: Chun Yan So
Session: Cocktail & Poster Display session
Resources:
Abstract
80P - Suppression of glioblastoma progression by FDA-approved central nervous system-accumulating drugs via autophagy modulation and ER stress-induced apoptosis
Presenter: Smita Dey
Session: Cocktail & Poster Display session
Resources:
Abstract
81P - Evaluating the effect of lenvatinib-resistance in hepatocellular carcinoma cells and in lenvatinib-resistant patient-derived PBMCs
Presenter: Luisa Amato
Session: Cocktail & Poster Display session
Resources:
Abstract